Browsing by Author "Seyahi, Nurhan"

Now showing 1 - 14 of 14

Amyloid a amyloidosis after renal transplantation: An important cause of mortality
(Lippincott Williams & Wilkins, 2020-08-01) Sarıhan, İrem; Çalışkan, Yaşar; Mirioğlu, Şafak; Özlük, Yasemin; Senates, Banu; Seyahi, Nurhan; Baştürk, Taner; Yıldız, Abdulmecit; Kılıçaslan, Işin; Sever, Mehmet Şükrü; YILDIZ, ABDULMECİT; Bursa Uludağ Üniversitesi/Tıp Fakültesi/Dahiliye Bölümü; HIG-9032-2022
Background. There are limited data on the outcome of transplant recipients with familial Mediterranean fever (FMF)-associated AA amyloidosis. The aim of the present study is to evaluate demographic, clinical, laboratory, and prognostic characteristics and outcome measures of these patients. Methods. Eighty-one renal transplant recipients with FMF-associated AA amyloidosis (group 1) and propensity score-matched transplant recipients (group 2, n = 81) with nonamyloidosis etiologies were evaluated in this retrospective, multicenter study. Recurrence of AA amyloidosis was diagnosed in 21 patients (group 1a), and their features were compared with 21 propensity score-matched recipients with FMF amyloidosis with no laboratory signs of recurrence (group 1b). Results. The risk of overall allograft loss was higher in group 1 compared with group 2 (25 [30.9%] versus 12 [14.8%];P= 0.015 [hazard ratio, 2.083; 95% confidence interval, 1.126-3.856]). Patients in group 1 were characterized by an increased risk of mortality compared with group 2 (11 [13.6%] versus 0%;P= 0.001 [hazard ratio, 1.136; 95% confidence interval, 1.058-1.207]). Kaplan-Meier analysis revealed that 5- and 10-year patient survival rates in group 1 (92.5% and 70.4%) were significantly lower than in group 2 (100% and 100%;P= 0.026 andP= 0.023, respectively). Although not reaching significance, overall, 5- and 10-year graft survival rates (57.1%, 94.7%, and 53.8%, respectively) in group 1a were worse than in group 1b (76.2%, 95%, and 77.8%, respectively;P= 0.19,P= 0.95, andP= 0.27, respectively). Conclusions. AA amyloidosis is associated with higher risk of mortality after kidney transplantation. Inflammatory indicators should be monitored closely, and persistent high levels of acute-phase reactants should raise concerns about amyloid recurrence in allograft.
Characteristics and survival results of peritoneal dialysis patients suffering from COVID-19 in Turkey: A multicenter national study
(Karger, 2022-09-13) Gürsu, Meltem; Öztürk, Savaş; Arıcı, Mustafa; Şahin, İdris; Gökçay Bek, Sibel; Yılmaz, Mürvet; Koyuncu, Sümeyra; Karahisar Sıralı, Semahat; Ural, Zeynep; Dursun, Belda; Yüksel, Enver; Uzun, Sami; Sipahi, Savaş; Ahbap, Elbis; Artan, Ayşe Serra; Altunören, Orçun; Tunca, Onur; Ayar, Yavuz; Gök-Oğuz, Ebru; Yılmaz, Zülfükar; Kahvecioğlu, Serdar; Aşıcıoğlu, Ebru; Oruç, Ayşegül; Altıparmak, Mehmet Rıza; Aydın, Zeki; Huddam, Bülent; Dolarslan, Mürşide Esra; Azak, Alper; Bakirdoğen, Serkan; Yalçın, Ahmet Uğur; Karadağ, Serhat; Ulu, Memnune Sena; Güngör, Özkan; Arı Bakir, Elif; Odabas, Ali Riza; Seyahi, Nurhan; Yıldız, Alaattin; Ateş, Kenan; ORUÇ, AYŞEGÜL; Bursa Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı/Nefroloji Anabilim Dalı.; 0000-0002-0342-9692 ; AAH-4002-2021
Background: We aimed to study the characteristics of peritoneal dialysis (PD) patients with Coronavirus disease-19 (COVID-19), determine the short-term mortality and other medical complications, and delineate the factors associated with COVID-19 outcome.Methods: In this multicenter national study, we included PD patients with confirmed COVID-19 from 27 centers. The baseline demographic, clinical, laboratory, and radiological data and outcomes at the end of the first month were recorded.Results: We enrolled 142 COVID-19 patients (median age:52 years). 58.2% of patients had mild disease at diagnosis. Lung involvement was detected in 60.8% of patients. 83 (58.4%) patients were hospitalized, 31 (21.8%) patients were admitted to intensive care unit and 24 needed mechanical ventilation. 15 (10.5%) patients were switched to hemodialysis and hemodiafiltration was performed for four (2.8%) patients. Persisting pulmonary symptoms (n=27), lower respiratory system infection (n=12), rehospitalization for any reason (n=24), malnutrition (n=6), hypervolemia (n=13), peritonitis (n=7), ultrafiltration failure (n=7) and in PD modality change (n=8) were reported in survivors. 26 patients (18.31%) died in the first month of diagnosis. The non-survivor group was older, comorbidities were more prevalent. Fever, dyspnea, cough, serious-vital disease at presentation, bilateral pulmonary involvement, and pleural effusion were more frequent among non-survivors. Age (OR:1.102; 95%CI: 1.032-1.117; p: 0.004), moderate-severe clinical disease at presentation (OR:26.825; 95%CI: 4.578-157.172; p<0.001) and baseline CRP (OR:1.008; 95%CI; 1.000-1.016; p:0.040) were associated with first-month mortality in multivariate analysis.Conclusions: Early mortality rate and medical complications are quite high in PD patients with COVID-19. Age, clinical severity of COVID-19, and baseline CRP level are the independent parameters associated with mortality.
Characteristics of primary glomerular diseases patients with hematuria in Turkey: the data from TSN-GOLD Working Group
(Springer, 2020-10-27) Şumnu, Abdullah; Türkmen, Kültigin; Cebeci, Egemen; Türkmen, Aydın; Eren, Necmi; Seyahi, Nurhan; Oruç, Ayşegül; Dede, Fatih; Derici, Ülver; Baştürk, Taner; Şahin, Garip; Sipahioğlu, Murat; Şahin, Gülizar Manga; Tatar, Erhan; Dursun, Belda; Sipahi, Savaş; Yılmaz, Mürvet; Süleymanlar, Gültekin; Ulu, Sena; Güngör, Özkan; Kutlay, Sim; Bahçebaşı, Zerrin Bicik; Şahin, İdris; Kurultak, İlhan; Sevinç, Can; Yılmaz, Zülfikar; Kazancıoğlu, Rümeyza Turan; Çavdar, Caner; Candan, Ferhan; Aydın, Zeki; Oygar, Deren; Gül, Bülent; Altun, Bülent; Paydaş, Saime; Uzun, Sami; İstemihan, Zülal; Ergül, Metin; Dinçer, Mevlüt Tamer; Güllulü, Mustafa; Pişkinpaşa, Serhan; Akçay, Ömer Faruk; Ünsal, Abdulkadir; Koyuncu, Sümeyra; Gök, Mahmut; Öztürk, Savaş; ORUÇ, AYŞEGÜL; GÜLLÜLÜ, MUSTAFA; Bursa Uludağ Üniversitesi/Tıp Fakültesi/Nefroloji Anabilim Dalı.; 0000-0002-0342-9692; AAH-4002-2021; CTG-8811-2022
Purpose Hematuria is one of the most common laboratory findings in nephrology practice. To date, there is no enough data regarding the clinical and histopathologic characteristics of primary glomerular disease (PGD) patients with hematuria in our country. Methods Data were obtained from national multicenter (47 centers) data entered into the Turkish Society of Nephrology Glomerular Diseases (TSN-GOLD) database between May 2009 and June 2019. The data of all PGD patients over the age of 16 years who were diagnosed with renal biopsy and had hematuria data were included in the study. Demographic characteristics, laboratory and biopsy findings were also recorded. Results Data of 3394 PGD patients were included in the study. While 1699 (50.1%) patients had hematuria, 1695 (49.9%) patients did not have hematuria. Patients with hematuria had statistically higher systolic blood pressure, serum blood urea nitrogen, creatinine, albumin, levels and urine pyuria. However, these patients had statistically lower age, body mass index, presence of hypertension and diabetes, eGFR, 24-h proteinuria, serum total, HDL and LDL cholesterol, and C3 levels when compared with patients without hematuria. Hematuria was present 609 of 1733 patients (35.8%) among the patients presenting with nephrotic syndrome, while it was presented in 1090 of 1661 (64.2%) patients in non-nephrotics (p < 0.001). Conclusion This is the first multicenter national report regarding the demographic and histopathologic data of PGD patients with or without hematuria. Hematuria, a feature of nephritic syndrome, was found at a higher than expected in the PGDs presenting with nephrotic syndrome in our national database.
Demographic and clinical characteristics of primary glomerular diseases in Turkey
(Springer, 2014-12-01) Öztürk, Savaş; Sumnu, Abdullah; Seyahi, Nurhan; Sipahioglu, Murat; Artan, Serra; Bicik, Zerrin; Kutlay, Sim; Keles, Mustafa; Oygar, Deren; Odabas, Ali Riza; Kayatas, Mansur; Dursun, Belda; Sayarlioglu, Hayriye; Trablus, Sinan; Taymez, Dilek Guven; Özdemir, Ali Abbas; Sahin, Gulizar Manga; Altun, Bulent; Azak, Alper; Altıntepe, Lutfullah; Suleymanlar, Gultekin; Koc, Mehmet; Selcuk, Yilmaz; Kazancıoğlu, Rumeyza; Erkoç, Reha; Gursu, Meltem; Küçük, Mehmet; Akçaoglu, Selma Alagöz; Yıldız, Abdulmecid; Ünal, Aydın; Akarsu, Özger; Ates, Kenan; Cankaya, Erdem; Türkmen, Aydın; Güllülü, Mustafa; GÜLLÜLÜ, MUSTAFA; Bursa Uludağ Üniversitesi/Tıp Fakültesi/Nefroloji Anabilim Dalı.
The aim of our study was to delineate the demographic and clinical properties of primary glomerular diseases of adult population in our country in the light of global knowledge.All over the country, a total of 25 centers entered data between May 2009 and July 2012 to the database created by 'Glomerulonephritis Study Group' of Turkish Society of Nephrology. Demographic and clinical characteristics, specific diagnoses of glomerular diseases and biopsy findings recorded to the database were analyzed.Among the 1,274 patients, who had renal biopsy within the defined time period, 55 % were male and 45 % were female. The mean age was 40.8 +/- A 14.6 years. The most frequent indication for biopsy was nephrotic syndrome (57.8 %), followed by nephritic syndrome including rapidly progressive glomerulonephritis (16.6 %) and asymptomatic urinary abnormalities (10.8 %). The most frequent primary glomerular disease was membranous nephropathy (28.8 %), followed by focal segmental glomerulosclerosis (19.3 %) and IgA nephropathy (17.2 %).The presented study displayed important data about the epidemiology of primary glomerular diseases among adults in our country. The predominance of membranous nephropathy in contrast to other countries, in which the most frequent etiology is IgA nephropathy, seems to be due to differences in the indications for renal biopsy.
Epidemiological and clinical characterstics of iga nephropathy patients in turkey: Tsn-gold working group
(Oxford Univ Press, 2020-06-01) Eren, Necmi; Gürsu, Meltem; Cebeci, Egemen; Türkmen, Aydın; Yeter, Hasan Hacı; Seyahi, Nurhan; Pişkinpaşa, Serhan Vahit; Ersoy, Alpaslan; Baştürk, Taner; Şahin, Gülizar Manga; Yücel, Fatma Sibel Koçak; Genç, Ahmed Bilal; Şahin, Garip; Ulu, Memnune Sena; Soyhan, Merve; Türkmen, Kültigin; Özberk, Sümeyra; Elcioglu, Omer; Altunören, Orçun; Şahin, İdris; Kutlay, Sim; Ustündağ, Sedat; Kalender, Betül; Dede, Fatih; Altun, Bülent; Ersoy, Alpaslan; Bursa Uludağ Üniversitesi/Tıp Fakültesi/Nefroloji Anabilim Dalı.; 0000-0002-0710-0923; AAH-5054-2021
Is the severity of glomerular igg staining in patient with iga nephropathy useful for predicting poor renal prognosis? The data from Tsn-gold working group
(Oxford University Press, 2020-06-01) Turgutalp, Kenan; Cebeci, Egemen; Türkmen, Aydin; Derici, Ülver; Seyahi, Nurhan; Eren, Necmi; Dede, Fatih; Güllülü, Mustafa; Baştürk, Taner; Şahin, Gülizar Manga; Yılmaz, Mürvet; Sipahi, Savaş; Şahin, Garip; Ulu, Memnune Sena; Tatar, Erhan; Gündoğdu, Ali; Kazancıoğlu, Rümeyza Turan; Sevinç, Can; Güngör, Özkan; Şahin, İdris; Kutlay, Sim; Kurultak, İlhan; Aydın, Zeki; Altun, Bülent; Dursun, Belda; Yılmaz, Zülfikar; Uzun, Özcan; Süleymanlar, Gültekin; Candan, Ferhan; Sezer, Siren; Tanburoğlu, Derya Başak; Bahçebaşı, Zerrin Bicik; Taymez, Dilek Güven; Oygar, Deren; Akçalı, Esra; İstemihan, Zulal; Akçay, Ömer Faruk; Dinçer, Mevlüt Tamer; Ergül, Metin; Yenigün, Ezgi; Türkmen, Kültigin; Öztürk, Savaş; GÜLLÜLÜ, MUSTAFA; Bursa Uludağ Üniversitesi/Tıp Fakültesi.; CTG-8811-2022
Membranous nephropathy in Turkey: Turkish society of nephrology glomeruler diseases (tsn-gold) database results
(Oxford University Press, 2020-06-01) Yıldız, Abdülmecit; Ulu, Memnune Sena; Oruç, Ayşegül; Uçar, Ali Rıza; Öztürk, Savaş; Alagöz, Selma; Eren, Necmi; Koçyiğit, İsmail; Cevher, Simal Köksal; Haraş, Ali Burak; Sumnu, Abdullah; Arınsoy, Turgay; Şahin, Garip; Süleymanlar, Gültekin; Çavdar, Caner; Gahin, Gizem Kumru; Kurultak, İlhan; Ünsal, Abdülkadir; Şahin, Gülizar Manga; Kazan, Sinan; Vatansever, Bülent; Dikeç, Mehmet; Dursun, Belda; Sayarlıoğlu, Hayriye; Türkmen, Kultiin; Artan, Ayşe Serra; Aktaş, Nimet; Yılmaz, Zülfikar; Behlül, Ahmet; Dheir, Hamad; Kutlay, Sim; Seyahi, Nurhan; YILDIZ, ABDULMECİT; ORUÇ, AYŞEGÜL; Bursa Uludağ Üniversitesi/Tıp Fakültesi.; 0000-0002-0342-9692; AAH-4002-2021; HIG-9032-2022
Recurrent AA amyloidosis after renal transplantation: Effects on allograft survival
(Oxford University, 2016-05) Sarıhan, İrem; Şenateş, Banu; Mirioğlu, Şafak; Seyahi, Nurhan; Baştürk, Taner; Altıparmak, Mehmet Rıza; Caliskan, Yaşar; Sever, Mehmet Şükrü; Yıldız, Abdülmecit; Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı/Nefroloji Bilim Dalı.; HIG-9032-2022
Relationship between disease awareness and severity of kidney disease in autosomal dominant polycystic kidney disease patients
(Wiley, 2022-05-10) Doğan, Ege; Eren, Necmi; Özcan, Seyda Gül; Altunoren, Orçun; Güngor, Özkan; Dheir, Hamad; Tanrısev, Mehmet; Koçyigit, Hafsa; Yıldız, Abdulmecit; Koçyiğit, Ismail; Seyahi, Nurhan; Tatar, Erhan; YILDIZ, ABDULMECİT; Uludağ Üniversitesi/Tıp Fakültesi/Nefroloji Anabilim Dalı; HIG-9032-2022
Introduction Polycystic kidney disease (PKD) is responsible for 5%-10% of end-stage renal disease. We examined the relationship between renal and extrarenal findings, disease severity, and the level of consciousness of PKD patients. Methods Patients were asked to answer the questionnaire about PKD. Disease severity was determined according to estimated glomerular filtration rate, and disease awareness was assessed by adapting the Disease Perception Scale to PKD. Awareness of patients was evaluated comparatively with chronic kidney disease stage, age, region, and symptoms. Results One out of five patients does not know that this disease is inherited. Mean awareness scores of the patients decreased significantly with increasing age. Awareness scores were significantly higher in patients with flank pain, hematuria, and urinary tract stones. Conclusion Although PKD is the most common hereditary kidney disease, the rate of patients' knowledge on this subject is low. Increased awareness might lead to better treatment in those patients.
The importance of complement levels and clinical characteristics of primary membranoproliferative glomerulonephritis in Turkey
(Oxford Univ Press, 2020-06-01) Tatar, Erhan; Oygar, Deren; Seyahi, Nurhan; Eren, Necmi; Cantürk, Yağmur; Güngor, Özkan; Derici, Ulver; Sipahioğlu, Murat; Sümnü, Abdullah; Odabaş, Ali Riza; Turgut, Didem; Çavdar, Caner; Şahin, Garip; Dursun, Belda; Taymez, Dilek Güven; Aydın, Fatma Yılmaz; Ulu, Memnune Sena; Baştürk, Taner; Yadigar, Serap; Bozacı, Ilter; Behlül, Ahmet; Sipahi, Savaş; Bahçebaşı, Zerrin Bicik; Karadag, Serhat; Yıldız, Abdulmecit; YILDIZ, ABDULMECİT; Bursa Uludağ Üniversitesi/Tıp Fakültesi; HIG-9032-2022
The longitudinal evolution of post-COVID-19 outcomes among hemodialysis patients in Turkey
(Elsevier Science Inc, 2022-06-03) Ozturk, Savas; Turgutalp, Kenan; Arici, Mustafa; Gorgulu, Numan; Tonbul, Halil Zeki; Eren, Necmi; Gencer, Vedat; Ayli, Mehmet Deniz; Pembegul, Irem; Dolarslan, Murside Esra; Ural, Zeynep; Colak, Hulya; Ozler, Tuba Elif; Can, Ozgur; Demir, Mehmet Emin; Altunoren, Orcun; Huddam, Bulent; Onec, Kursad; Demirelli, Bulent; Aydin, Zeki; Altun, Eda; Alagoz, Selma; Ayar, Yavuz; Eser, Zeynep Ebru; Berktas, Bayram; Yilmaz, Zulfukar; Ates, Eser Uslu; Yuksel, Enver; Sahin, Gizem Kumru; Aktar, Merve; Cebeci, Egemen; Dursun, Belda; Kocak, Sibel Yucel; Yıldız, Abdülmecit; Kazan, Sinan; Gok, Mahmut; Sengul, Erkan; Tugcu, Murat; Ozturk, Ramazan; Kahvecioglu, Serdar; Kara, Ekrem; Kaya, Bulent; Sahin, Garip; Sakaci, Tamer; Sipahi, Savas; Kurultak, Ilhan; Durak, Beyza Algul; Altiparmak, Mehmet Riza; Ecder, Sabahat Alisir; Karadag, Serhat; Dincer, Mevlut Tamer; Ozer, Hakan; Bek, Sibel Gokcay; Ulu, Memnune Sena; Gungor, Ozkan; Bakir, Elif Ari; Odabas, Ali Riza; Seyahi, Nurhan; Yildiz, Alaattin; Ates, Kenan; YILDIZ, ABDULMECİT; Bursa Uludağ Üniversitesi/Tıp Fakültesi/Nefroloji Anabilim Dalı.; HIG-9032-2022
Introduction: Hemodialysis (HD) patients have increased risk for short-term adverse outcomes of COVID-19. However, complications and survival at the post-COVID-19 period have not been published extensively.Methods: We conducted a national, multicenter observational study that included adult maintenance HD patients recovered from confirmed COVID-19. A control HD group without COVID-19 was selected from patients in the same center. We investigated the characteristics and outcomes in the follow-up of HD patients and compare them with the non-COVID-19 group.Results: A total of 1223 patients (635 patients in COVID-19 group, 588 patients in non-COVID-19 group) from 47 centers were included in the study. The patients' baseline and HD characteristics were almost similar. The 28th-day mortality and mortality between 28th day and 90th day were higher in the COVID-19 group than non-COVID-19 group (19 [3.0%] patients vs. none [0%]; 15 [2.4%] patients vs. 4 [0.7%] patients, respectively). The presence of respiratory symptoms, rehospitalization, need for home oxygen therapy, lower respiratory tract infection, and arteriovenous (AV) fistula thrombosis was significantly higher in the COVID-19 group in both the first 28 days and between 28 and 90 days. In the multivariable analysis, age (odds ratio [OR] [95% CI]: 1.029 [1.004-1.056]), group (COVID-19 group vs. non-COVID-19 group) (OR [95% CI]: 7.258 [2.538-20.751]), and vascular access type (tunneled catheter/AV fistula) (OR [95% CI]: 2.512 [1.249-5.051]) were found as independent parameters related to 90-day mortality.Conclusion: In the post-COVID-19 period, maintenance HD patients who have had COVID-19 have increased rehospitalization, respiratory problems, vascular access problems, and high mortality compared with the non-COVID-19 HD patients.
The relationship between glomerular igg staining and poor prognostic findings in patients with iga nephropathy: The data from tsn-gold working group
(BMC, 2021-10-28) Turgutalp, Kenan; Cebeci, Egemen; Turkmen, Aydin; Derici, Ulver; Seyahi, Nurhan; Eren, Necmi; Dede, Fatih; Basturk, Taner; Sahin, Gulizar Manga; Yilmaz, Murvet; Sipahi, Savas; Sahin, Garip; Ulu, Sena; Tatar, Erhan; Gundogdu, Ali; Kazancioglu, Rumeyza Turan; Sevinc, Can; Gungor, Ozkan; Sahin, Idris; Kutlay, Sim; Kurultak, Ilhan; Aydin, Zeki; Altun, Bulent; Dursun, Belda; Yilmaz, Zulfikar; Uzun, Ozcan; Suleymanlar, Gultekin; Candan, Ferhan; Sezer, Siren; Tanburoglu, Derya Basak; Bahcebasi, Zerrin Bicik; Taymez, Dilek; Akcali, Esra; Oygar, Deren; Istemihan, Zulal; Bardak, Simge; Akcay, Omer Faruk; Dincer, Mevlut Tamer; Dervisoglu, Erkan; Yenigun, Ezgi; Turkmen, Kultigin; Ozturk, Savas; Güllülü, Mustafa; GÜLLÜLÜ, MUSTAFA; Bursa Uludağ Üniversitesi/Tıp Fakültesi.; 0000-0003-0245-1844; 0000-0001-7427-618X; 0000-0002-2708-3470; 0000-0002-0409-2710; 0000-0001-6829-121X; 0000-0002-5068-4231; 0000-0002-9594-4121; 0000-0002-4069-9181; 0000-0002-8683-3737; 0000-0001-5607-1375; 0000-0002-6648-6053; 0000-0002-4017-0640; 0000-0002-6851-4871; 0000-0002-0961-3810; P-9618-2015; HKV-4703-2023; GRX-9954-2022; V-1616-2019; AAA-8435-2020; AFR-4244-2022; JYQ-2550-2024; S-7661-2016; AAS-4390-2020; Q-6320-2019; R-1388-2018
Background Galactose-deficient IgA1 (Gd-IgA1) has an increased tendency to form immunocomplexes with IgG in the serum, contributing to IgAN pathogenesis by accumulating in the glomerular mesangium. Several studies showed that glomerular IgG deposition in IgAN is an important cause of mesangial proliferation and glomerular damage. This study aims to determine the association of the positivity of IgG and the intensity of IgG staining with a poor renal prognosis. Methods A total of 943 IgAN patients were included in the study. Glomerular IgG staining negative and positive patients were compared using Oxford classification scores, histopathological evaluations, proteinuria, eGFR, albumin, blood pressures. IgG positive patients were classified as (+), (++), (+++) based on their staining intensity, and the association with the prognostic criteria was also evaluated. Results 81% (n = 764) of the patients were detected as IgG negative, while 19% (n = 179) were positive. Age, gender, body mass index, blood pressure, proteinuria, eGFR, uric acid values were similar in IgG positive and negative patients who underwent biopsy (p > 0.05). Intensity of glomerular IgG positivity was not found to be associated with diastolic and systolic blood pressure, urea, uric acid, age, eGFR, albumin, proteinuria (p > 0.05 for all, r = - 0.084, r = - 0.102, r = - 0.006, r = 0.062, r = 0.014, r = - 0.044, r = - 0.061, r = - 0.066, r = 0.150, respectively). There was no difference for histopathological findings between IgG (+), IgG (++), IgG (+++) groups (for all, p > 0.05). Conclusion Glomerular IgG negativity and positivity detected by routine IFM in IgAN patients is not associated with poor renal prognostic risk factors.
The relationship between severity of interstitial fibrosis and anemia in patient with primary glomerulonephritis: The data from TSN-gold working group
(Oxford Univ Press, 2020-06-01) Cebeci, Egemen; Turgutalp, Kenan; Öztürk, Savaş; Özlük, Yasemin; Bek, Sibel Gökçay; Şumnu, Abdullah; Seyahi, Nurhan; Yavuz, Mahmut; Pişkinpaşa, Serhan Vahit; Akçay, Ömer Faruk; Sakaci, Tamer; Şahin, Garip; Tokgöz, Bülent; Şahin, Gülizar Manga; Bozacı, Ilter; Dursun, Belda; Sipahi, Savaş; Kayalar, Arzu Özdemir; Süleymanlar, Gültekin; Ulu, Memnune Sena; Güzel, Fatma Betül; Kutlay, Sim; Parmaksız, Ergün; Koz, Süleyman; Kurultak, İlhan; Selçuk, Nedim Yılmaz; Yildırım, Yaşar; Gürsu, Meltem; Çavdar, Caner; Timuçin, Meryem; Aydın, Zeki; Oygar, Deren; Kahvecioğlu, Serdar; Kibar, Müge Uzerk; Torun, Dilek; Taymez, Dilek Güven; Küçük, Mehmet; Demir, Serap; Koç, Leyla; Sezer, Siren; Duranay, Murat; Bardak, Simge; Altintepe, Lüftullah; Koç, Mehmet; Azak, Alper; Odabaş, Ali Rıza; Yılmaz, Zülfikar; Paydaş, Saime; YAVUZ, MAHMUT; Bursa Uludağ Üniversitesi/Tıp Fakültesi/Nefroloji Anabilim Dalı.; EHM-7377-2022
Trends of primary glomerular disease in Turkey from 2009 to 2017: A regional registry report from tsn-gold working group
(Oxford Univ, 2020-06-01) Gül, Cuma Bülent; Küçük, Mehmet; Öztürk, Savaş; Demir, Erol; Eren, Necmi; Süönü, Abdullah; Seyahi, Nurhan; Dede, Fatih; Derici, Ülver; Koç, Yener; Şahin, Garip; Oymak, Oktay; Şahin, Gulizar Manga; Tatar, Erhan; Dursun, Belda; Dheir, Hamad; Apaydın, Suheyla; Süleymanlar, Gültekin; Ulu, Memnune Sena; Altunören, Orçun; Kutlay, Sim; Meşe, Meral; Şahin, İdris; Üstündağ, Sedat; Türkmen, Kultiğin; Yılmaz, Mehmet Emin; Kazancıoğlu, Rümeyza Turan; Uzun, Özcan; Candan, Ferhan; Aydın, Zeki; Oygar, Deren; Aktaş, Nimet; Erdem, Yunus; Paydaş, Saime; Taymez, Dilek Güven; Can, Başak; Kiykim, Ahmet; Koç, Leyla; Sezer, Siren; Duranay, Murat; Bardak, Simge; Altıntepe, Lüftullah; Kaya, Burcu; Azak, Alper; Ecder, Sabahat Alışır; Cavdar, Caner; Selçuk, Nedim Yılmaz; Güllülü, Mustafa; GÜLLÜLÜ, MUSTAFA; Bursa Uludağ Üniversitesi/Tıp Fakültesi/Nefroloji Anabilim Dalı.; CTG-8811-2022